Oral anticoagulant/platelet inhibitor low dose formulation

Details Oral anticoagulant/platelet inhibitor low dose formulation Oral anticoagulant/platelet inhibitor low dose formulation

1989-09-18

1991-08-20

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ortho-hydroxybenzoic acid or derivative doai

5142265, 514301, 514404, 514420, 514457, A61K 3135, A61K 3140, A61K 3144, A61K 3154, A61K 3162, A61K 31415

Patent

active

050414305

ABSTRACT:
There are disclosed combination products useful for the treatment and/or prevention of a first or recurrent myocardial infarction or a first or recurrent stroke. Said combination products comprise low doses of an oral anticoagulant, preferably warfarin and platelet inhibiting agents, including non-steroidal antiinflammatory agents and preferrably aspirin.

REFERENCES:
patent: 4444777 (1984-04-01), Fleming et al.
patent: 4537894 (1985-08-01), Blanchard et al.

Affiliated with

Also associated with

Rating

Oral anticoagulant/platelet inhibitor low dose formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral anticoagulant/platelet inhibitor low dose formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral anticoagulant/platelet inhibitor low dose formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1008031